Las partículas individuales del fármaco proporcionan una sensación en boca suave y agradable, sin regusto.
Microencapsulación por coacervación:
- Recubrimiento uniforme de una partícula sólida o gota líquida con un polímero semipermeable rígido
- Crea una barrera física
- Enmascaramiento eficaz del sabor
- Perfil de liberación personalizado
- Convertir líquidos no acuosos en polvo
- Combinar API incompatibles
Las formas farmacéuticas finales pueden producirse en:
- Polvos
- Jarabes secos
- Comprimidos de desintegración oral
- Forma farmacéutica Parvulet®: textura blanda similar a la de los alimentos
Hable con un experto
Dr. Srinivasan Shanmugam
Director Principal de Ciencias Farmacéuticas, Apoyo Empresarial y Nuevas Tecnologías
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
